Abstract
To compare the lifetime cost-effectiveness of once-daily 25 mg Empagliflozin, 5 mg Linagliptin, and 1000 mg Metformin XR triple-fixed-dose combination (FDC) versus its dual FDC of 25 mg Empagliflozin and 5 mg Linagliptin plus Metformin and its individual components.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
